Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › 2-amino-N'-benzylideneacetohydrazides and derivatives for the management of CFTR protein mediated diseases

2-amino-N'-benzylideneacetohydrazides and derivatives for the management of CFTR protein mediated diseases

US Patent 11116736 · Granted Sep 14, 2021

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Barbituric acid derivatives, their preparation and use thereof as leukocyte tran2025
Barbituric acid derivatives, their preparation and use thereof as leukocyte tran2025
3-(phenyl)-N-(4-phenoxybenzyl)-1,2,4-oxadiazole-5-carboxamide compounds for the 2023
3-(phenyl)-N-(4-phenoxybenzyl)-1,2,4-oxadiazole-5-carboxamide compounds for the 2023
Barbituric acid derivatives, their preparation and use thereof as leukocyte tran2022
3-(phenyl)-N-(4-phenoxybenzyl)-1,2,4-oxadiazole-5-carboxamide compounds for the 2021
3-(phenyl)-N-(4-phenoxybenzyl)-1,2,4-oxadiazole-5-carboxamide compounds for the 2021
Adjusting device for a vehicle seat2021
2-amino-N′-benzylideneacetohydrazides and derivatives for the management of CFTR2020
2-amino-N′-benzylideneacetohydrazides and derivatives for the management of CFTR2020
2-amino-N′-benzylideneacetohydrazides and derivatives for the management of CFTR2020
2-amino-N′-benzylideneacetohydrazides and derivatives for the management of CFTR2020